Loading stock data…
NervGen Pharma Corp. (NGEN)
$1.96+0.09 (+4.81%)
After Hours$2.00+0.04 (+2.04%)· Last close Jun 29
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NervGen Pharma Corp. in the Healthcare sector is trading at $1.96 with a market capitalization of $199M. Wall Street consensus targets $11.21 (6 analysts), implying a +471.7% move over the next 12 months. The stock is currently near its 52-week low of $1.70, remaining 45.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +471.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$7.53M↓ | -$6.40M↓ | -$6.17M↑ | -$6.47M↓ | -$6.04M |
| Net Income | -$1.68M↑ | -$26.91M↓ | -$4.16M↑ | -$9.10M↓ | -$3.95M |
Peer Comparison
JNJUNHPFE
Fundamentals
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product ca...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$198.60M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.69
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1203.50%
Volume
Today's trading volume
804,368
